Evolent Health (EVH) Debt/EBITDA US GAAP (year values) |
||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
Debt/EBITDA | -1.09 | -0.08 | 0.25 | 6.58 | -18.2 | 8.29 | ||
Changes by years, y/y, % | -223% | -93% | -419% | +2 482% | -377% |
Evolent Health. Debt/EBITDA
Evolent Health. Debt/EBITDA, changes, %
Evolent Health (EVH) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 191.5 | 10.4 | 9.77 | 5.54 | 8.04 | 8.29 | ||
Changes by years, y/y, % | +390% | -208% | -163% | -92% | -88% | |||
Changes by quarters, q/q, % | +181% | -95% | -6% | -43% | +45% |